{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:51:10Z","timestamp":1785844270220,"version":"3.56.0"},"reference-count":54,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Perioperative management of antirheumatic medications in adults with rheumatoid arthritis (RA) undergoing orthopedic surgery requires balancing postoperative infection and impaired wound healing against disease flare, pain, and delayed rehabilitation. This systematic review aimed to evaluate how perioperative continuation, withholding, interruption timing, restart timing, dose modification, or exposure to antirheumatic medications relates to postoperative outcomes in adults with RA undergoing arthroplasty and non-arthroplasty orthopedic procedures. PubMed, Scopus, and the Cochrane Central Register of Controlled Trials were searched from database inception to 18 April 2026 for English-language full-text clinical studies. The primary outcomes were surgical site infection\/periprosthetic joint infection, delayed wound healing, and postoperative RA flare. Secondary outcomes included reoperation, revision, readmission, mortality, venous thromboembolism, dislocation, and other procedure-specific complications. Original studies were classified as direct perioperative strategy evidence, medication-exposure evidence, or supportive clinical-context evidence. Forty-three original clinical studies were included, together with six non-original contextual sources. The evidence was predominantly observational, clinically heterogeneous, and of very low certainty. Methotrexate continuation was not associated with an evident increase in early postoperative complications, whereas direct evidence for other conventional synthetic agents was limited. Longer interruption of biologic or targeted synthetic therapy did not consistently reduce infection or wound-healing complications, while several studies associated treatment interruption with postoperative flare. Chronic baseline glucocorticoid exposure was associated with adverse outcomes but was clinically distinct from short-term perioperative administration; stress-dose supplementation was not directly evaluated. Medication decisions should therefore be individualized according to drug class, disease control, glucocorticoid burden, surgical procedure, and patient risk profile.<\/jats:p>","DOI":"10.3390\/medicina62081498","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:38:08Z","timestamp":1785839888000},"page":"1498","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perioperative Management of Antirheumatic Medications in Adults with Rheumatoid Arthritis Undergoing Arthroplasty and Other Orthopedic Procedures: A Systematic Review"],"prefix":"10.3390","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4486-5247","authenticated-orcid":false,"given":"Ibrahim","family":"Al-Obaidi","sequence":"first","affiliation":[{"name":"Sheikh Tahnoon Bin Mohammed Medical City, PureHealth, Al Ain P.O. Box 15258, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6854-7041","authenticated-orcid":false,"given":"Ibrahim","family":"Alabid","sequence":"additional","affiliation":[{"name":"RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afra","family":"Al-Dhaheri","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Tawam\/Sheikh Tahnoon Bin Mohammed Medical City Hospital, PureHealth, Al Ain P.O. Box 15258, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain Al-Abdeen Mohammed","family":"Qassim","sequence":"additional","affiliation":[{"name":"RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6948-3619","authenticated-orcid":false,"given":"Mohamedanas Mohamedfaruk","family":"Patni","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"El-Tanani","sequence":"additional","affiliation":[{"name":"RAK College of Pharmacy, RAK Medical and Health Science University, Ras Al Khaimah 11172, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8454-8158","authenticated-orcid":false,"given":"Syed Arman","family":"Rabbani","sequence":"additional","affiliation":[{"name":"RAK College of Pharmacy, RAK Medical and Health Science University, Ras Al Khaimah 11172, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aesha","family":"Shuaeeb","sequence":"additional","affiliation":[{"name":"Sheikh Tahnoon Bin Mohammed Medical City, PureHealth, Al Ain P.O. Box 15258, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9497-3781","authenticated-orcid":false,"given":"Radwan Abdulaziz","family":"Aloti","sequence":"additional","affiliation":[{"name":"RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7791-0942","authenticated-orcid":false,"given":"Wasim I. I.","family":"Alghoul","sequence":"additional","affiliation":[{"name":"RAK College of Medical Sciences, RAK Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"ref_1","unstructured":"GBD 2021 Rheumatoid Arthritis Collaborators (2023). Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: A systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol., 5, e594\u2013e610."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/ard-2022-223356","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update","volume":"82","author":"Smolen","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"251962","DOI":"10.5402\/2012\/251962","article-title":"Wound healing with medications for rheumatoid arthritis in hand surgery","volume":"2012","author":"Barnard","year":"2012","journal-title":"ISRN Rheumatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/107110070402500510","article-title":"Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy","volume":"25","author":"Bibbo","year":"2004","journal-title":"Foot Ankle Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e0033","DOI":"10.2106\/JBJS.OA.17.00033","article-title":"Total ankle arthroplasty for rheumatoid arthritis in Japanese patients: A retrospective study of intermediate to long-term follow-up","volume":"2","author":"Hirao","year":"2017","journal-title":"JBJS Open Access"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"751.e1","DOI":"10.1016\/j.jhsa.2026.03.003","article-title":"Perioperative biologic disease-modifying antirheumatic drugs, risks of infections, and wound complications in patients with rheumatoid arthritis undergoing elective hand surgery","volume":"51","author":"Cathey","year":"2026","journal-title":"J. Hand Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"779.e1","DOI":"10.1016\/j.jhsa.2020.02.005","article-title":"The management of perioperative immunosuppressant medications for rheumatoid arthritis during elective hand surgery","volume":"45","author":"Klifto","year":"2020","journal-title":"J. Hand Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.foot.2017.01.009","article-title":"The implications of biologic therapy for elective foot and ankle surgery in patients with rheumatoid arthritis","volume":"30","author":"Diaper","year":"2017","journal-title":"Foot"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3904\/kjim.2021.555","article-title":"Perioperative and anesthetic management of patients with rheumatoid arthritis","volume":"37","author":"Kim","year":"2022","journal-title":"Korean J. Intern. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/mr\/roac042","article-title":"Surgical intervention for patients with rheumatoid arthritis is declining except for foot and ankle surgery: A single-centre, 20-year observational cohort study","volume":"33","author":"Tominaga","year":"2023","journal-title":"Mod. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/art.40149","article-title":"2017 American College of Rheumatology\/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty","volume":"69","author":"Goodman","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/acr.24893","article-title":"2022 American College of Rheumatology\/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty","volume":"74","author":"Goodman","year":"2022","journal-title":"Arthritis Care Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/14397595.2021.1913824","article-title":"Comprehensive risk analysis of postoperative complications in patients with rheumatoid arthritis for the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis","volume":"32","author":"Ito","year":"2022","journal-title":"Mod. Rheumatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jbspin.2016.06.011","article-title":"Infectious risk associated to orthopaedic surgery for rheumatoid arthritis patients treated by anti-TNFalpha","volume":"84","author":"Mabille","year":"2017","journal-title":"Jt. Bone Spine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Nishida, K., Nasu, Y., Harada, R., Nakahara, R., Horita, M., Natsumeda, M., Naniwa, S., and Ozaki, T. (2026). Perioperative ozoralizumab management for patients with rheumatoid arthritis who underwent orthopaedic surgery: A retrospective case series. J. Clin. Med., 15.","DOI":"10.3390\/jcm15041422"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"R145","DOI":"10.1186\/ar3087","article-title":"Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor \u03b1-blockers: A case-control study","volume":"12","author":"Gilson","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13075-025-03683-9","article-title":"Does perioperative discontinuation of anti-rheumatic drugs increase postoperative complications in orthopedic surgery for rheumatoid arthritis?","volume":"27","author":"Ito","year":"2025","journal-title":"Arthritis Res. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1186\/s13018-024-04924-4","article-title":"Association between disease activity of rheumatoid arthritis and risk of complications following total hip arthroplasty: A retrospective cohort study","volume":"19","author":"Lai","year":"2024","journal-title":"J. Orthop. Surg. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/M18-2217","article-title":"Risk of biologics and glucocorticoids in patients with rheumatoid arthritis undergoing arthroplasty: A cohort study","volume":"170","author":"George","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1038\/s41598-025-94342-1","article-title":"Increased early complication rates following total hip arthroplasty in rheumatoid arthritis patients based on a Japanese nationwide medical claims database study","volume":"15","author":"Mori","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1136\/ard.60.3.214","article-title":"Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery","volume":"60","author":"Grennan","year":"2001","journal-title":"Ann. Rheum. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/01.RHU.0000062514.54375.bd","article-title":"Examination of the risk of continuous leflunomide treatment on the incidence of infectious complications after joint arthroplasty in patients with rheumatoid arthritis","volume":"9","author":"Tanaka","year":"2003","journal-title":"J. Clin. Rheumatol."},{"key":"ref_24","first-page":"689","article-title":"Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: A large retrospective study","volume":"34","author":"Creemers","year":"2007","journal-title":"J. Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/acr.23209","article-title":"Perioperative timing of infliximab and the risk of serious infection after elective hip and knee arthroplasty","volume":"69","author":"George","year":"2017","journal-title":"Arthritis Care Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1756-185X.2010.01579.x","article-title":"Clinical factors related to the efficacy and complications of orthopedic surgery for rheumatoid arthritis with infliximab","volume":"14","author":"Hayata","year":"2011","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/rheumatology\/kep376","article-title":"Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-alpha blockers: Perioperative interruption of tumour necrosis factor-alpha blockers decreases complications?","volume":"49","author":"Kawakami","year":"2010","journal-title":"Rheumatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/acr.23843","article-title":"Timing of abatacept before elective arthroplasty and risk of postoperative outcomes","volume":"71","author":"George","year":"2019","journal-title":"Arthritis Care Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3109\/s10165-012-0683-0","article-title":"Analysis of perioperative clinical features and complications after orthopaedic surgery in rheumatoid arthritis patients treated with tocilizumab in a real-world setting: Results from the multicentre TOcilizumab in Perioperative Period (TOPP) study","volume":"23","author":"Momohara","year":"2013","journal-title":"Mod. Rheumatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/mr\/road114","article-title":"Complications after orthopaedic surgeries in patients with rheumatoid arthritis treated with Janus kinase inhibitors: A retrospective observational study","volume":"34","author":"Bekki","year":"2024","journal-title":"Mod. Rheumatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/mr\/road047","article-title":"Influence of Janus kinase inhibitors on early postoperative complications in patients with rheumatoid arthritis undergoing orthopaedic surgeries","volume":"34","author":"Nishida","year":"2024","journal-title":"Mod. Rheumatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1111\/os.14150","article-title":"Perioperative short-term glucocorticoids do not increase incidence of complications after total joint arthroplasty in patients with rheumatoid arthritis","volume":"16","author":"Lai","year":"2024","journal-title":"Orthop. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Yi, J.W., Kim, S.H., Bang, S.M., and Cho, B.K. (2025). The effect of the modification of perioperative anti-rheumatic medications on early complications after total ankle arthroplasty for severe rheumatoid arthritis. J. Clin. Med., 14.","DOI":"10.3390\/jcm14207280"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/14397595.2015.1073133","article-title":"Risk factors for surgical site infection and delayed wound healing after orthopedic surgery in rheumatoid arthritis patients","volume":"26","author":"Kadota","year":"2016","journal-title":"Mod. Rheumatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/mr\/roae089","article-title":"The use of biologic disease-modifying antirheumatic drugs does not increase surgical site infection or delayed wound healing after orthopaedic surgeries for rheumatoid arthritis","volume":"35","author":"Kiso","year":"2025","journal-title":"Mod. Rheumatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3109\/s10165-012-0612-2","article-title":"Perioperative complications in elective surgery in patients with rheumatoid arthritis treated with biologics","volume":"22","author":"Kubota","year":"2012","journal-title":"Mod. Rheumatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/s10165-011-0423-x","article-title":"Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs","volume":"21","author":"Momohara","year":"2011","journal-title":"Mod. Rheumatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s00776-011-0142-3","article-title":"Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: A report from the Committee on Arthritis of the Japanese Orthopaedic Association","volume":"16","author":"Suzuki","year":"2011","journal-title":"J. Orthop. Sci."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s10067-016-3274-1","article-title":"Delayed wound healing and postoperative surgical site infections in patients with rheumatoid arthritis treated with or without biological disease-modifying antirheumatic drugs","volume":"35","author":"Tada","year":"2016","journal-title":"Clin. Rheumatol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/14397595.2015.1071456","article-title":"Longer operative time is the risk for delayed wound healing after forefoot surgery in patients with rheumatoid arthritis","volume":"26","author":"Yano","year":"2016","journal-title":"Mod. Rheumatol."},{"key":"ref_41","first-page":"286","article-title":"Changes in perioperative C-reactive protein levels in patients with rheumatoid arthritis undergoing total knee arthroplasty in the biologic era","volume":"84","author":"Kishimoto","year":"2022","journal-title":"Nagoya J. Med. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/acr.23499","article-title":"Orthopedic surgery among patients with rheumatoid arthritis: A population-based study to identify risk factors, sex differences, and time trends","volume":"70","author":"Richter","year":"2018","journal-title":"Arthritis Care Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/art.24060","article-title":"Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis","volume":"59","author":"Bongartz","year":"2008","journal-title":"Arthritis Rheum."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Borgas, Y., G\u00fclfe, A., Kindt, M., and Stef\u00e1nsd\u00f3ttir, A. (2020). Anti-rheumatic treatment and prosthetic joint infection: An observational study in 494 elective hip and knee arthroplasties. BMC Musculoskelet. Disord., 21.","DOI":"10.1186\/s12891-020-03459-z"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"22704","DOI":"10.1038\/s41598-021-02153-x","article-title":"Acute surgical site infection after total knee arthroplasty in patients with rheumatoid arthritis versus osteoarthritis","volume":"11","author":"Chung","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/annrheumdis-2017-212339","article-title":"Predictors of revision, prosthetic joint infection and mortality following total hip or total knee arthroplasty in patients with rheumatoid arthritis: A nationwide cohort study using Danish healthcare registers","volume":"77","author":"Cordtz","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.semarthrit.2019.06.007","article-title":"Risk of medical complications following total hip or knee arthroplasty in patients with rheumatoid arthritis: A register-based cohort study from Denmark","volume":"50","author":"Cordtz","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"152201","DOI":"10.1016\/j.semarthrit.2023.152201","article-title":"Perioperative treatment with TNF inhibitors does not affect survival of total hip arthroplasty in inflammatory arthritis: A registry-based cohort study","volume":"60","author":"Ursini","year":"2023","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.5371\/hp.2024.36.4.273","article-title":"Biological agent and total hip arthroplasty in rheumatoid arthritis","volume":"36","author":"Takakubo","year":"2024","journal-title":"Hip Pelvis"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3109\/14397595.2013.844387","article-title":"Does use of a biologic agent increase the incidence of postoperative infection in surgery for rheumatoid arthritis after total joint arthroplasty?","volume":"24","author":"Kubota","year":"2014","journal-title":"Mod. Rheumatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/14397595.2019.1702252","article-title":"Factors associated with disease activity after orthopaedic surgery in patients with rheumatoid arthritis","volume":"30","author":"Yamada","year":"2020","journal-title":"Mod. Rheumatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/14397595.2020.1790138","article-title":"Risk factors of postoperative delayed wound healing in patients with rheumatoid arthritis treated with a biological agent","volume":"31","author":"Okita","year":"2021","journal-title":"Mod. Rheumatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13075-022-02767-0","article-title":"Risk factor analysis of perioperative complications in patients with rheumatoid arthritis undergoing primary cervical spine surgery","volume":"24","author":"Sakuraba","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e084997","DOI":"10.1136\/bmjopen-2024-084997","article-title":"PERI-operative biologic DMARD management: Stoppage or COntinuation during orthoPaEdic operations (the PERISCOPE trial)\u2014A study protocol for a pragmatic, UK multicentre, superiority randomised controlled trial with an internal pilot, economic evaluation and nested qualitative study","volume":"14","author":"Brady","year":"2024","journal-title":"BMJ Open"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1498\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:43:31Z","timestamp":1785843811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/8\/1498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["medicina62081498"],"URL":"https:\/\/doi.org\/10.3390\/medicina62081498","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]}}}